NL-OMON33122
Completed
Not Applicable
Adherence and patients' experiences with the use of erlotinib in NSCLC treatment: The influence on plasma concentration and the exploration of factors affecting the use in daily practice - Adherence and patients* experiences with erlotinib
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- non-small-cell-lung cancer or lung cancer
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 50
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •NSCLC patients starting with erlotinib
Exclusion Criteria
- •younger than 18 year
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practicecolorectal cancergastric cancer and breast cancer10017991NL-OMON36444Vrije Universiteit Medisch Centrum90
Completed
Not Applicable
Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databasesParkison's diseaseJPRN-UMIN000052869Eisai Co., Ltd.
Recruiting
Not Applicable
Impact on adherence to treatment of patients with Diabetes at the basic health unit with telephone follow-up: a randomized clinical trialDiabetes Mellitus, Type 2C18.452.394.750RBR-10nsmwztniversidade Federal de São Paulo
Completed
Not Applicable
A Comparison of Patient Adherence and Preference of Packaging Method for Oral Anticancer Agents Using Conventional Pill Bottles versus Daily Pill BoxesAdvanced solid tumorsCancerSolid tumoursISRCTN74558413Princess Margaret Hospital (Canada)25
Completed
Not Applicable
Adherence and patients’ experiences with capecitabine.Colorectal cancer, gastric cancer and breast cancer.NL-OMON21382VU University Medical Center66